Concepts (192)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Quality of Life | 14 | 2023 | 505 | 1.910 |
Why?
|
| Ostomy | 11 | 2018 | 30 | 1.800 |
Why?
|
| Cancer Survivors | 7 | 2019 | 115 | 1.620 |
Why?
|
| Rectal Neoplasms | 10 | 2018 | 75 | 1.610 |
Why?
|
| Survivors | 8 | 2017 | 157 | 1.070 |
Why?
|
| Surveys and Questionnaires | 10 | 2025 | 1296 | 0.810 |
Why?
|
| Cystectomy | 2 | 2019 | 7 | 0.770 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2019 | 57 | 0.730 |
Why?
|
| Autism Spectrum Disorder | 1 | 2023 | 164 | 0.640 |
Why?
|
| Health Plan Implementation | 1 | 2019 | 33 | 0.610 |
Why?
|
| Comparative Effectiveness Research | 1 | 2019 | 59 | 0.600 |
Why?
|
| Community Health Centers | 1 | 2019 | 56 | 0.590 |
Why?
|
| Genetic Testing | 5 | 2025 | 73 | 0.580 |
Why?
|
| Guideline Adherence | 1 | 2019 | 155 | 0.560 |
Why?
|
| Humans | 39 | 2025 | 17622 | 0.550 |
Why?
|
| Female | 30 | 2025 | 12715 | 0.520 |
Why?
|
| Self Care | 1 | 2018 | 144 | 0.520 |
Why?
|
| Colorectal Neoplasms | 4 | 2018 | 642 | 0.480 |
Why?
|
| Male | 20 | 2025 | 10014 | 0.470 |
Why?
|
| Adult | 23 | 2025 | 7621 | 0.470 |
Why?
|
| Middle Aged | 16 | 2025 | 7954 | 0.410 |
Why?
|
| Spirituality | 1 | 2013 | 2 | 0.400 |
Why?
|
| Premature Birth | 4 | 2020 | 136 | 0.350 |
Why?
|
| Decision Making | 3 | 2019 | 177 | 0.350 |
Why?
|
| Minority Groups | 2 | 2023 | 104 | 0.330 |
Why?
|
| Aged | 14 | 2025 | 6223 | 0.320 |
Why?
|
| Young Adult | 9 | 2019 | 2538 | 0.310 |
Why?
|
| Gynecology | 2 | 2020 | 22 | 0.310 |
Why?
|
| Pregnancy | 11 | 2020 | 1565 | 0.290 |
Why?
|
| Adolescent | 8 | 2023 | 3625 | 0.290 |
Why?
|
| Oregon | 6 | 2020 | 172 | 0.290 |
Why?
|
| Anastomosis, Surgical | 3 | 2017 | 10 | 0.260 |
Why?
|
| Long Term Adverse Effects | 2 | 2017 | 5 | 0.260 |
Why?
|
| Adaptation, Psychological | 2 | 2013 | 79 | 0.250 |
Why?
|
| Colectomy | 2 | 2016 | 31 | 0.240 |
Why?
|
| Washington | 5 | 2020 | 388 | 0.240 |
Why?
|
| Genetic Counseling | 2 | 2023 | 27 | 0.240 |
Why?
|
| Influenza, Human | 2 | 2020 | 294 | 0.240 |
Why?
|
| Social Justice | 1 | 2025 | 8 | 0.220 |
Why?
|
| Body Weight | 2 | 2016 | 203 | 0.220 |
Why?
|
| Genome, Human | 1 | 2025 | 33 | 0.220 |
Why?
|
| Weight Gain | 2 | 2016 | 165 | 0.210 |
Why?
|
| Prospective Studies | 3 | 2023 | 1251 | 0.210 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2023 | 6 | 0.210 |
Why?
|
| Life Style | 1 | 2025 | 321 | 0.200 |
Why?
|
| Delivery of Health Care | 2 | 2019 | 383 | 0.200 |
Why?
|
| Evidence-Based Medicine | 1 | 2024 | 173 | 0.190 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2019 | 46 | 0.190 |
Why?
|
| Child Health | 1 | 2023 | 43 | 0.190 |
Why?
|
| Gestational Age | 4 | 2016 | 119 | 0.190 |
Why?
|
| Infant, Premature | 2 | 2016 | 59 | 0.180 |
Why?
|
| Health Literacy | 1 | 2022 | 38 | 0.180 |
Why?
|
| Research Report | 1 | 2022 | 23 | 0.180 |
Why?
|
| Quality Improvement | 1 | 2023 | 189 | 0.180 |
Why?
|
| Postpartum Period | 2 | 2013 | 93 | 0.180 |
Why?
|
| Child | 3 | 2023 | 2485 | 0.160 |
Why?
|
| Urogenital System | 1 | 2020 | 2 | 0.160 |
Why?
|
| Vulvovaginitis | 1 | 2020 | 3 | 0.160 |
Why?
|
| Urologic Diseases | 1 | 2020 | 7 | 0.160 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2020 | 157 | 0.160 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2000 | 9 | 0.160 |
Why?
|
| Menopause | 1 | 2020 | 68 | 0.160 |
Why?
|
| Urinary Bladder | 1 | 2019 | 10 | 0.160 |
Why?
|
| Urinary Diversion | 1 | 2019 | 3 | 0.150 |
Why?
|
| Decision Support Techniques | 1 | 2020 | 88 | 0.150 |
Why?
|
| Infant, Newborn | 6 | 2020 | 842 | 0.150 |
Why?
|
| Influenza Vaccines | 2 | 2020 | 301 | 0.150 |
Why?
|
| Child Development | 1 | 2020 | 57 | 0.150 |
Why?
|
| Self Report | 2 | 2018 | 262 | 0.150 |
Why?
|
| Socioeconomic Factors | 4 | 2013 | 603 | 0.150 |
Why?
|
| Thinness | 2 | 2016 | 31 | 0.150 |
Why?
|
| Pregnant Women | 1 | 2019 | 46 | 0.140 |
Why?
|
| Child, Preschool | 1 | 2023 | 1455 | 0.140 |
Why?
|
| Postoperative Complications | 2 | 2017 | 99 | 0.140 |
Why?
|
| Patient Selection | 1 | 2019 | 181 | 0.140 |
Why?
|
| Prenatal Care | 1 | 2019 | 129 | 0.130 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 308 | 0.130 |
Why?
|
| Research Design | 1 | 2019 | 337 | 0.130 |
Why?
|
| Primary Health Care | 2 | 2020 | 729 | 0.130 |
Why?
|
| Population Surveillance | 1 | 2019 | 248 | 0.130 |
Why?
|
| Employment | 1 | 2018 | 44 | 0.130 |
Why?
|
| Activities of Daily Living | 1 | 2018 | 80 | 0.130 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 1976 | 0.130 |
Why?
|
| Parents | 1 | 2000 | 301 | 0.130 |
Why?
|
| Blood Glucose | 1 | 2019 | 319 | 0.130 |
Why?
|
| California | 3 | 2019 | 2433 | 0.130 |
Why?
|
| Social Participation | 1 | 2017 | 3 | 0.130 |
Why?
|
| Defecation | 1 | 2017 | 6 | 0.130 |
Why?
|
| Rectum | 1 | 2017 | 13 | 0.130 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2016 | 12 | 0.130 |
Why?
|
| Ethnic Groups | 1 | 2019 | 443 | 0.120 |
Why?
|
| Recreation | 1 | 2017 | 39 | 0.120 |
Why?
|
| Organ Sparing Treatments | 1 | 2016 | 3 | 0.120 |
Why?
|
| Health Services | 2 | 2019 | 110 | 0.120 |
Why?
|
| Infant, Postmature | 1 | 2015 | 1 | 0.120 |
Why?
|
| Birth Certificates | 1 | 2015 | 24 | 0.120 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2019 | 380 | 0.110 |
Why?
|
| Health Status | 2 | 2018 | 291 | 0.110 |
Why?
|
| Gastrointestinal Diseases | 1 | 2015 | 27 | 0.110 |
Why?
|
| Body Mass Index | 3 | 2016 | 959 | 0.110 |
Why?
|
| Medical Records | 1 | 2015 | 91 | 0.110 |
Why?
|
| Sexual Behavior | 1 | 2016 | 129 | 0.110 |
Why?
|
| Pregnancy Complications | 2 | 2016 | 208 | 0.100 |
Why?
|
| Vaccination | 1 | 2019 | 726 | 0.100 |
Why?
|
| Diabetes, Gestational | 2 | 2019 | 328 | 0.100 |
Why?
|
| Mass Screening | 1 | 2019 | 693 | 0.100 |
Why?
|
| Fetal Macrosomia | 1 | 2013 | 27 | 0.100 |
Why?
|
| Pregnancy Outcome | 4 | 2016 | 162 | 0.100 |
Why?
|
| Sickness Impact Profile | 1 | 2013 | 25 | 0.100 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2013 | 55 | 0.100 |
Why?
|
| Diet | 1 | 2015 | 355 | 0.100 |
Why?
|
| Infant Care | 1 | 2013 | 7 | 0.100 |
Why?
|
| Maternal Death | 1 | 2012 | 2 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2025 | 384 | 0.090 |
Why?
|
| Depression, Postpartum | 1 | 2013 | 27 | 0.090 |
Why?
|
| Child Health Services | 1 | 2013 | 107 | 0.090 |
Why?
|
| Interviews as Topic | 1 | 2013 | 324 | 0.090 |
Why?
|
| Term Birth | 1 | 2012 | 9 | 0.090 |
Why?
|
| Exercise | 1 | 2017 | 538 | 0.090 |
Why?
|
| Cross-Sectional Studies | 4 | 2017 | 1295 | 0.090 |
Why?
|
| Anxiety Disorders | 1 | 2013 | 100 | 0.090 |
Why?
|
| Qualitative Research | 1 | 2013 | 290 | 0.090 |
Why?
|
| Anxiety | 1 | 2013 | 162 | 0.090 |
Why?
|
| Prognosis | 3 | 2019 | 609 | 0.090 |
Why?
|
| Social Support | 1 | 2013 | 215 | 0.090 |
Why?
|
| Longitudinal Studies | 3 | 2019 | 686 | 0.090 |
Why?
|
| Receptor, ErbB-2 | 1 | 2011 | 47 | 0.080 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2011 | 29 | 0.080 |
Why?
|
| Infant | 4 | 2020 | 1228 | 0.080 |
Why?
|
| Risk Factors | 4 | 2023 | 3291 | 0.080 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2011 | 43 | 0.080 |
Why?
|
| Depression | 1 | 2015 | 507 | 0.080 |
Why?
|
| Health Maintenance Organizations | 1 | 2012 | 403 | 0.080 |
Why?
|
| Cohort Studies | 4 | 2019 | 2502 | 0.080 |
Why?
|
| Follow-Up Studies | 3 | 2017 | 1157 | 0.070 |
Why?
|
| Length of Stay | 3 | 2013 | 182 | 0.070 |
Why?
|
| Anal Canal | 2 | 2017 | 9 | 0.060 |
Why?
|
| United States | 3 | 2025 | 3922 | 0.060 |
Why?
|
| Retrospective Studies | 3 | 2019 | 2502 | 0.060 |
Why?
|
| Glucose Tolerance Test | 2 | 2019 | 108 | 0.060 |
Why?
|
| Patient Preference | 2 | 2016 | 49 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 2 | 2019 | 80 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 689 | 0.060 |
Why?
|
| Whole Genome Sequencing | 1 | 2024 | 10 | 0.050 |
Why?
|
| Incidental Findings | 1 | 2024 | 28 | 0.050 |
Why?
|
| Infant, Newborn, Diseases | 2 | 2015 | 34 | 0.050 |
Why?
|
| Logistic Models | 2 | 2018 | 866 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2011 | 1005 | 0.050 |
Why?
|
| Delivery, Obstetric | 2 | 2013 | 18 | 0.050 |
Why?
|
| Chromosome Mapping | 1 | 2022 | 18 | 0.050 |
Why?
|
| Data Collection | 1 | 2022 | 234 | 0.040 |
Why?
|
| Communication | 1 | 2022 | 181 | 0.040 |
Why?
|
| Syndrome | 1 | 2020 | 28 | 0.040 |
Why?
|
| Neoplasms | 1 | 2025 | 457 | 0.040 |
Why?
|
| Vaccines, Inactivated | 1 | 2020 | 73 | 0.040 |
Why?
|
| Atrophy | 1 | 2019 | 6 | 0.040 |
Why?
|
| Attitude | 1 | 2019 | 28 | 0.040 |
Why?
|
| Prenatal Diagnosis | 1 | 2019 | 20 | 0.040 |
Why?
|
| Glucose Intolerance | 1 | 2019 | 46 | 0.040 |
Why?
|
| Family Characteristics | 1 | 2019 | 70 | 0.040 |
Why?
|
| Patient Satisfaction | 1 | 2019 | 193 | 0.030 |
Why?
|
| Volunteers | 1 | 2018 | 9 | 0.030 |
Why?
|
| Survivorship | 1 | 2018 | 12 | 0.030 |
Why?
|
| Hispanic Americans | 1 | 2019 | 370 | 0.030 |
Why?
|
| European Continental Ancestry Group | 1 | 2019 | 470 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2016 | 22 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2016 | 26 | 0.030 |
Why?
|
| Sexual Partners | 1 | 2016 | 36 | 0.030 |
Why?
|
| Health Surveys | 1 | 2016 | 242 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2015 | 92 | 0.030 |
Why?
|
| Focus Groups | 1 | 2015 | 144 | 0.030 |
Why?
|
| Survival Rate | 1 | 2015 | 252 | 0.030 |
Why?
|
| Disease Management | 1 | 2015 | 110 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2014 | 35 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 350 | 0.030 |
Why?
|
| Psychometrics | 1 | 2014 | 119 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 363 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2015 | 269 | 0.020 |
Why?
|
| Georgia | 1 | 2012 | 15 | 0.020 |
Why?
|
| Morbidity | 1 | 2012 | 59 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2013 | 268 | 0.020 |
Why?
|
| Medicaid | 1 | 2013 | 188 | 0.020 |
Why?
|
| Cesarean Section | 1 | 2012 | 35 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2011 | 22 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2011 | 15 | 0.020 |
Why?
|
| Trastuzumab | 1 | 2011 | 19 | 0.020 |
Why?
|
| SEER Program | 1 | 2011 | 92 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 63 | 0.020 |
Why?
|
| Continental Population Groups | 1 | 2012 | 283 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 1038 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2012 | 163 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 402 | 0.020 |
Why?
|
Concepts
(192)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(20)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
-->